Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome

• Egile Nagusiak: M. Boyadzhiev (Egilea), L. Marinov (Egilea), V. Boyadzhiev (Egilea), V. Iotova (Egilea), I. Aksentijevich (Egilea), S. Hambleton (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2019-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background CANDLE syndrome (an acronym for Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature) is a recently described rare autosomal recessive disorder charaterized by systemic autoinflammation. Clinical manifestations include presentation in the first yea...